Back to Search
Start Over
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Source :
- Business Wire. September 5, 2024
- Publication Year :
- 2024
-
Abstract
- WALTHAM, Mass. -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the 'company' or 'Viridian'), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced [...]
- Subjects :
- Stock options
Compensation management
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.807392720